Related Experiment Video
Updated: Feb 13, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
MHC-I genotype drives early immune selection of oncogenic mutations
Rachel Marty1,2, Nicola de Prisco3, Hannah Carter1,2,4,5
1Department of Medicine, Division of Medical Genetics, University of California San Diego, La Jolla, CA, USA.
Abstract:
MHC-I exposes the intracellular contents to immune cells for surveillance of cellular health. Due to high genomic variation, individuals' immune systems differ in their ability to expose and eliminate cancer-causing mutations. These personalized immune blind spots create specific oncogenic mutation predispositions within patients and influence their prevalence across populations.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
What is Natural Selection?
Mutation, Gene Flow, and Genetic Drift
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...

